| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Ivabradine in the treatment of congenital junctional ectopic tachycardia: A systematic review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Syed Faqeer Hussain Bokhari, Muhammad Muaz Mushtaq, Maham Mushtaq, Husnain Ali, Danyal Bakht, Muhayya Faizullah, Almas Asghar, Muhammad Khan Buhadur Ali, Muhammad Asad Sarwar, Maryyam Liaqat, Asma Iqbal and Wahidullah Dost |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wahidullah Dost, Curative Medicine, Kabul University of Medical Sciences, Karte-e-sakhi Kabul, Kabul 10001, Kābul, Afghanistan. wahidullahdost96@gmail.com |
| Key Words |
Ivabradine; Congenital junctional ectopic tachycardia; Neonates; Infants; Refractory |
| Core Tip |
Ivabradine, a selective hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, shows promise in managing congenital junctional ectopic tachycardia (CJET) in neonates and infants, especially when conventional antiarrhythmic therapies fail. This systematic review highlights ivabradine's efficacy in controlling heart rate, achieving sinus rhythm, and stabilizing junctional rhythm, with no significant adverse effects reported. Despite the encouraging results, further prospective studies with larger sample sizes and extended follow-up are necessary to establish ivabradine's definitive role in CJET management. |
| Publish Date |
2025-04-21 08:12 |
| Citation |
<p>Bokhari SFH, Mushtaq MM, Mushtaq M, Ali H, Bakht D, Faizullah M, Asghar A, Buhadur Ali MK, Sarwar MA, Liaqat M, Iqbal A, Dost W. Ivabradine in the treatment of congenital junctional ectopic tachycardia: A systematic review. <i>World J Cardiol</i> 2025; 17(4): 104465</p> |
| URL |
https://www.wjgnet.com/1949-8462/full/v17/i4/104465.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v17.i4.104465 |
